NCT00854152View on ClinicalTrials.gov

A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Non-Hodgkin's Lymphoma, Solid Cancers
Interventions
DRUG

GDC-0980

Escalating repeating dose

Trial Locations (5)

10065

New York

37203

Nashville

60637

Chicago

02115

Boston

SM2 5PT

Sutton

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY